logo
Death toll rises to 36 following an explosion and fire at a southern India pharmaceutical factory

Death toll rises to 36 following an explosion and fire at a southern India pharmaceutical factory

Yahooa day ago
HYDERABAD, India (AP) — The death toll from Monday's massive explosion and fire at a pharmaceutical factory in India's southern state of Telangana has risen to at least 36 while about three dozen were left injured, authorities said Tuesday.
The fire department recovered the charred bodies of 34 workers from the accident site in an industrial area about 50 kilometers (31 miles) from the state capital Hyderabad, the state's fire services director G.V. Narayana Rao told The Associated Press.
Two other workers succumbed to burns and were pronounced dead in hospital, Rao said, adding that debris of the gutted pharmaceutical unit of Sigachi Industries was still being removed to find out if any more workers were trapped.
Nearly three dozen injured workers were admitted to hospitals, he said.
'The whole structure of the factory has collapsed. Fire has been doused, and we hope to finish removing the debris in the next few hours,' Rao said.
The explosion and subsequent fire was reported on Monday in the factory's spray dryer unit, which is used to process raw material into fine powder for making drugs, Rao said.
The state's Health Minister Damodar Raja Narasimha said there were 108 workers inside the factory at the time of the explosion.
'As bodies were badly burnt and mutilated, a special medical team has been deployed to conduct DNA tests', said Narasimha, adding the state government has set up a panel to investigate the cause of the incident.
Witnesses said they heard the explosion from a couple of kilometers away from the site.
India is home to some of the world's top pharmaceutical companies, playing a pivotal role in the global supply of generic medicines and vaccines. The country's robust manufacturing and cost-effective production have made it a hub for pharma giants.
Industrial accidents, particularly involving chemical reactors, aren't uncommon in such factories, underlining the need for authorities to implement stringent safety protocols and regulatory oversight in a sector critical to public health.
Sigachi Industries Limited is an Indian company dealing with active pharmaceutical ingredients, intermediates and vitamin-mineral blends, according to the company's website. It has five manufacturing facilities across India and subsidiaries in the U.S and the United Arab Emirates.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Feeling Hoarse? You Might Have the New ‘Stratus' Covid Variant
Feeling Hoarse? You Might Have the New ‘Stratus' Covid Variant

WIRED

time7 hours ago

  • WIRED

Feeling Hoarse? You Might Have the New ‘Stratus' Covid Variant

Jul 2, 2025 5:00 AM The World Health Organization has added the variant, known formally as XFG, to its monitoring list. A dry, irritated throat is among its main symptoms. Photograph: loops7/Getty Images Another NEW covid variant is currently rapidly gaining a foothold. Known officially as XFG—or informally as 'Stratus'—it has been declared a 'variant under monitoring' by the World Health Organization (WHO), and is expected to circulate alongside the now dominant Nimbus variant throughout the northern hemisphere summer. The risk to public health is low, the WHO has said. Infections are characterized by a particular symptom: hoarseness. Stratus is a combination of the LF.7 and LP.8.1.2 lineages of the virus, and when comparing Stratus to the previously dominant JN1 variant, 'distinct mutational profiles in the spike protein can be identified,' the WHO has said. 'Spike mutations at amino acids 478 and 487 enhance antibody avoidance'—meaning, in other words, the variant may be more adept at evading our immune defenses. Stratus has been dominant in India throughout the spring, and has now started to spread at large across the world. Gisaid, a global initiative that tracks the spread of viral variants, reported that 22.7 percent of Covid samples submitted to it during the last week of May were Stratus, up from 7.4 percent four weeks earlier. These samples came from 38 different countries. Available data doesn't suggest that the variant causes more severe disease or deaths than others in circulation, though doctors in India have noted that hoarseness is a common symptom. Patients have also reported suffering a dry cough and sore throat, in addition to the more common Covid symptoms such as fever, muscle aches, and fatigue. 'The currently approved Covid-19 vaccines are expected to remain effective against this variant against symptomatic and severe disease,' the WHO stated in its risk assessment. The organization will continue to regularly assess the impact of this and other variants on the efficacy of vaccines, to guide decisions on vaccine updates. This story originally appeared on WIRED Italia and has been translated from Italian.

Ghana to Seek India's Backing for Vaccine Hub as Modi Visits
Ghana to Seek India's Backing for Vaccine Hub as Modi Visits

Bloomberg

timea day ago

  • Bloomberg

Ghana to Seek India's Backing for Vaccine Hub as Modi Visits

Ghana plans to ask India for support to develop a vaccine hub when Prime Minister Narendra Modi visits the West African nation this week. The two countries are expected to hold talks and sign agreements covering agriculture, defense and a vaccine hub, Foreign Affairs Minister Samuel Okudzeto Ablakwa told reporters in the capital, Accra. The African nation, which aims to become self-sufficient in inoculations by 2030 and a hub for vaccine production will seek to capitalize on the South Asian country's vast experience in pharmaceuticals, he said.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store